Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from Sanofi Pasteur MSD (manufacturer control number # 2015001188) as part of business agreement on 21-DEC-2015. Case received from a physician on 17-DEC-2015. A 13-year-old female adolescent patient received GARDASIL, (batch number unknown) via intramuscular route on 14-Apr-2010. Other suspect products included: Gardasil, (batch number unknown, Dose 2) administered via intramuscular route on 16-Jun-2010 -GARDASIL, (batch number unknown , Dose 3) administered via intramuscular route on 13-Dec-2010. The patient experienced Near syncope in DEC-2010, Dizziness in DEC-2010 and Exercise capacity decreased on an unknown date. Additional investigations included Tilt Table Test orthostatic intolerance n/a on an unknown date.Other HA comment: A tilt table test at the department showed orthostatic intolerance, but the patient does not fulfill the diagnostic criteria for POTS. Other medicines/and vaccines: unknown. 6 months after dose 2 of GARDASIL the patient attends a basketball tournament and get near syncope, then experience it several times with dizziness. Physical activity significantly reduced now.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166